Back
Protagonist Therapeutics Vs. UniFirst Industry Stock Comparison
Buy
66
PTGX
Protagonist Therapeutics
Last Price:
34.63
Seasonality Move:
-0.18%
Sell
47
UNF
UniFirst
Last Price:
171.30
Seasonality Move:
0.65%
Buy
66
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $34.65. The Score for PTGX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
UniFirst (UNF)
is a Sell
Is UniFirst a Buy, Sell or Hold?
- The current UniFirst [UNF] share price is $171.53. The Score for UNF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- UNF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $34.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.73 | Buy |
Relative Strength Index (14 RSI): | 63.74 | Buy |
Chaikin Money Flow: | 688414 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.74 - 33.96) | Buy |
Bollinger Bands (100): | (26.54 - 31.64) | Buy |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.69 | Buy |
Relative Strength Index (14 RSI): | 64.29 | Buy |
Chaikin Money Flow: | -178403 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (152.13 - 164.71) | Buy |
Bollinger Bands (100): | (158.4 - 170.62) | Buy |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.28 | Buy |
20-day SMA: | 32.49 | Buy |
50-day SMA: | 29.74 | Buy |
200-day SMA: | 24.17 | Buy |
8-day EMA: | 32.66 | Buy |
20-day EMA: | 32.14 | Buy |
50-day EMA: | 30.61 | Buy |
200-day EMA: | 26.01 | Buy |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 161.19 | Buy |
20-day SMA: | 157.78 | Buy |
50-day SMA: | 160.85 | Buy |
200-day SMA: | 167.26 | Buy |
8-day EMA: | 164.13 | Buy |
20-day EMA: | 160.47 | Buy |
50-day EMA: | 161.15 | Buy |
200-day EMA: | 166.52 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
UniFirst Earnings Growth & UNF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.16 per share, an increase this year of $0.94 per share, and an increase next year of $0.46 per share.
Protagonist Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |